Clinical Trial Update: Pioglitazone for Lung Cancer Chemoprevention [Phase 2]

View source ↗

Summary

Phase 2 trial update of pioglitazone for lung cancer chemoprevention has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endobronchial Dysplasia
• Lung Cancer

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Lung Cancer, Endobronchial Dysplasia | Phase 2 | Status: COMPLETED | Results posted: 2019-04-11